AI Terminal
Zur Rose Group AG
M&A Activity • Dec 29, 2017
1021_rns_2017-12-29_81c659d8-84b0-4e3a-bdb0-0960859a2229.html
M&A Activity
Open in ViewerOpens in native device viewer
News Details
Corporate | 29 December 2017 17:35
Zur Rose Group: Takeover of Eurapon and Vitalsana successfully concluded
EQS Group-News: Zur Rose Group AG / Key word(s): Takeover
29.12.2017 / 17:35
Press release
Zur Rose Group: Takeover of Eurapon and Vitalsana successfully concluded
Following approval by the competition authorities, the Zur Rose Group has successfully completed the takeover of Eurapon and Vitalsana. In the course of these transactions, the company acquired Eurapon Pharmahandel GmbH in Bremen (Germany), as well as the mail-order pharmacy Vitalsana B.V. in Heerlen (Netherlands) and the associated service provider ApDG GmbH in Ulm (Germany).
Contact
Pascale Ineichen, Communications Manager
e-mail: [email protected], telephone: +41 52 724 08 18
Zur Rose Group
Operating under the “Zur Rose” and “DocMorris” brands, the Swiss-based Zur Rose Group is Europe’s largest online pharmacy and one of Switzerland’s leading wholesale suppliers to medical doctors. Through its business model, it helps to ensure safe, reliable and high-quality pharmaceutical care, while also excelling in developing innovative medicines management services to increase the effectiveness of the medication process. This creation of added value, the strong focus on patients and the commitment to supply medication at low cost for the benefit of payors and patients make the Group an important strategic partner for all healthcare stakeholders.
Zur Rose Group is headquartered in Frauenfeld, from where it also serves the Swiss market. In Germany and Austria, the Group operates through subsidiaries in Heerlen (Netherlands) and Halle an der Saale (Germany). Furthermore, it holds a majority interest in BlueCare in Winterthur, the leading provider of networking systems in the Swiss healthcare market. Employing more than 800 people at its various locations, Zur Rose Group generated revenue of CHF 880 million in 2016.
Zur Rose Group AG’s shares (ticker symbol ROSE, Swiss security no. 4261528, ISIN CH0042615283) are traded on SIX Swiss Exchange in accordance with the International Reporting Standard of SIX Swiss Exchange. zurrosegroup.com
End of Corporate News
| Language: | English |
| Company: | Zur Rose Group AG |
| Walzmühlestrasse 60 | |
| 8500 Frauenfeld | |
| Switzerland | |
| Phone: | +41 52 724 08 14 |
| Internet: | www.zurrosegroup.com |
| ISIN: | CH0199729366, CH0042615283 |
| Listed: | SIX Swiss Exchange |
| End of News | EQS Group News Service |